Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesPsoriasis May Not Be an Independent Predictor for the Use of Cardiovascular and Anti-diabetic Drugs
Acta Dermato-Venereologica, 08/31/09
Wakkee M et al. – Psoriasis patients used significantly more anti–hypertensives, anti–coagulant and anti–platelet agents, digoxin, nitrates, lipid–lowering and anti–diabetic drugs than the reference population during a 5–year period observation. In a multiple linear regression model adjusting for the number of unique drugs used, psoriasis was no longer significantly associated with any of these drug classes. Psoriasis patients used more cardiovascular–related drugs, but surveillance bias appears to affect this association considerably.
Related Articles
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Relevance Score: 95%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Study shows major burden of psoriasis
Internet Source, 10/29/09
Relevance Score: 91%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 91%
Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09
Relevance Score: 91%
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Development and validation of nail psoriasis quality of life scale (NPQ10)
Journal of the European Academy of Dermatology and Venereology, 12/16/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor